A detailed history of Franklin Resources Inc transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 3,806,790 shares of DAWN stock, worth $50.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,806,790
Previous 4,236,795 10.15%
Holding current value
$50.5 Million
Previous $61.9 Million 1.67%
% of portfolio
0.02%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$13.56 - $17.46 $5.83 Million - $7.51 Million
-430,005 Reduced 10.15%
3,806,790 $62.9 Million
Q4 2023

Feb 09, 2024

BUY
$9.68 - $15.37 $1.64 Million - $2.6 Million
169,463 Added 4.17%
4,236,795 $61.9 Million
Q3 2023

Nov 13, 2023

BUY
$11.22 - $14.86 $18,670 - $24,727
1,664 Added 0.04%
4,067,332 $49.9 Million
Q2 2023

Aug 11, 2023

BUY
$11.74 - $14.47 $7.73 Million - $9.53 Million
658,797 Added 19.34%
4,065,668 $48.5 Million
Q1 2023

May 12, 2023

BUY
$12.75 - $23.41 $11.9 Million - $21.9 Million
934,022 Added 37.77%
3,406,871 $45.5 Million
Q4 2022

Feb 10, 2023

SELL
$18.77 - $22.0 $72,395 - $84,854
-3,857 Reduced 0.16%
2,472,849 $53.2 Million
Q3 2022

Nov 14, 2022

BUY
$16.44 - $26.57 $186,199 - $300,931
11,326 Added 0.46%
2,476,706 $49.6 Million
Q2 2022

Aug 11, 2022

BUY
$5.72 - $17.9 $5.28 Million - $16.5 Million
922,521 Added 59.79%
2,465,380 $44.1 Million
Q1 2022

May 13, 2022

BUY
$9.12 - $17.47 $5.3 Million - $10.2 Million
581,633 Added 60.51%
1,542,859 $15.3 Million
Q4 2021

Feb 11, 2022

BUY
$15.65 - $26.33 $5.8 Million - $9.76 Million
370,699 Added 62.77%
961,226 $16.2 Million
Q3 2021

Nov 12, 2021

BUY
$20.0 - $27.92 $1.43 Million - $2 Million
71,561 Added 13.79%
590,527 $14 Million
Q2 2021

Aug 13, 2021

BUY
$19.0 - $23.69 $9.86 Million - $12.3 Million
518,966 New
518,966 $11.8 Million

Others Institutions Holding DAWN

About Day One Biopharmaceuticals, Inc.


  • Ticker DAWN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,461,104
  • Market Cap $975M
  • Description
  • Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...
More about DAWN
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.